1. What are the main types of protein PTMs, and how are they different?
Protein post-translational modifications (PTMs) include phosphorylation, ubiquitination, glycosylation, and lysine acylations such as acetylation, lactylation, and succinylation. They differ in chemical structure, the enzymes that write/erase them, their typical cellular locations, and biological functions. For example, phosphorylation often reflects rapid signaling activation, ubiquitination is closely tied to protein degradation and trafficking, glycosylation is common on secreted and membrane proteins, and lysine acylations frequently connect protein regulation to cellular metabolic state.
2. Why does PTM proteomics usually require enrichment before LC–MS/MS?
Most PTM peptides are low in abundance relative to unmodified peptides, so direct LC–MS/MS can miss key modification sites. PTM enrichment concentrates modified peptides and reduces sample complexity, improving sensitivity, expanding PTM site coverage, and increasing confidence in site-specific PTM identification and quantification.
3. What PTM enrichment strategies are commonly used in mass spectrometry?
Common approaches include affinity-based capture (e.g., antibodies or binding proteins), chemical or lectin-based enrichment for glycopeptides, and chromatography or metal-affinity concepts that selectively retain modified peptides. The optimal enrichment strategy depends on the PTM type, sample matrix, and the desired balance between depth, specificity, and quantitative consistency.
4. What quantification methods do you offer for PTM proteomics (label-free vs TMT)?
MetwareBio provides label-free quantitative PTM proteomics, with both DDA and DIA acquisition options depending on study scale and reproducibility needs. Label-based quantification (e.g., TMT/iTRAQ) is not offered for PTM projects on this platform. Recommended acquisition mode and design are proposed based on sample number, expected effect size, and biological complexity.
5. DDA vs DIA for PTM analysis: which should I choose?
DDA is widely used for deep PTM site discovery and building rich identification lists, while DIA is often preferred for higher quantitative completeness and reproducibility across larger cohorts. Selection depends on whether the primary goal is discovery depth (often DDA) or consistent quantification across many samples (often DIA).
6. Which PTM should I profile for cancer research?
For cancer signaling and kinase pathway activation, phosphorylation profiling is typically the first choice. Ubiquitination profiling is highly relevant for proteostasis, DNA damage responses, and targeted protein degradation mechanisms. Lysine acetylation and lactylation can be valuable for studies of epigenetic regulation, tumor metabolism, hypoxia, and immune microenvironment effects. The best PTM depends on the specific hypothesis and pathway of interest.
7. Which PTM is most relevant for immunity and inflammation studies?
Phosphorylation is commonly used to map immune receptor signaling and downstream pathway activation. Ubiquitination is important for innate immune signaling, NF-κB regulation, and protein turnover control. Lactylation has gained attention for linking glycolysis-driven metabolic states to immune cell function and inflammatory phenotypes.
8. Which PTM is recommended for metabolism, mitochondria, and energy regulation research?
Lysine acylations are often highly informative. Acetylation and succinylation are frequently connected to mitochondrial enzymes and metabolic flux, while lactylation can reflect glycolytic activity and metabolic reprogramming. PTM site-level changes can help pinpoint regulated enzymes and pathways beyond total protein abundance.
9. When should N-glycoproteomics be considered instead of other PTMs?
N-glycoproteomics is especially useful when the focus is on secreted proteins, membrane proteins, receptors, cell–cell communication, or clinically relevant glycoproteins. It can support biomarker-oriented studies and functional characterization of glycosylation changes that are not captured by phosphorylation or lysine acylation profiling.